| CAP | Community-acquired pneumonia |
| GCs | Glucocorticoids |
| HTE | Heterogeneous treatment effect |
| ITEs | Individual treatment effects |
| SHAP | Shapley Additive Explanations |
| ICU | Intensive care unit |
| RSV | Respiratory Syncytial Virus |
| CAP | Community-acquired pneumonia |
| GCs | Glucocorticoids |
| HTE | Heterogeneous treatment effect |
| ITEs | Individual treatment effects |
| SHAP | Shapley Additive Explanations |
| ICU | Intensive care unit |
| RSV | Respiratory Syncytial Virus |